Esempio: Heart Attack

Cerca studi clinici per: Rifapentine

Totale 49 risultati

NCT03900858

Reclutamento

Short Course Rifapentine and Isoniazid for the Preventive Treatment of Tuberculosis(SCRIPT-TB)

Condizioni: Silicosis Tuberculosis
NCT04551573

Non ancora reclutando

A Study of the Pharmacokinetic and Pharmacodynamic Interactions Between Bictegravir, Tenofovir Alafenamide and Rifapentine in Healthy Adult Subjects

Condizioni: Tuberculosis; Hiv
NCT00809718

Completato

The Effect of Rifapentine on Raltegravir

Condizioni: Healthy
NCT03474029

Reclutamento

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

Condizioni: Latent Tuberculosis
NCT04703075

Non ancora reclutando

Treatment Success and Safety of 4 Weeks of Daily Rifapentine and Isoniazid (1HP) vs. 12 Weeks of Weekly Rifapentine and Isoniazid (3HP) for Prevention of Tuberculosis in HIV-uninfected Individuals (1v3HP for TPT in HIV-uninfected Individuals)

Condizioni: Tuberculosis
NCT01043575

Completato

High Dose Rifapentine Pharmacokinetics, Tolerability and Safety Dosage Rifapentine for Treatment of Tuberculosis

Condizioni: Smear Positive, Pan-sensitive, Pulmonary Tuberculosis
NCT04528277

Non ancora reclutando

Short Course Rifapentine and Isoniazid for the Preventive Treatment for Latent Genital Tuberculosis

Condizioni: Infertility, Female; Recurrent Implantation Failure; Genital Tuberculoses, Female; Genital Tuberculosis, Latent
NCT02410772

Stato sconosciuto

TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens

Condizioni: Tuberculosis
NCT00728507

Terminato

Rifapentine Plus Moxifloxacin for Treatment of Pulmonary Tuberculosis

Condizioni: Tuberculosis
NCT02980016

Completato

Evaluation of the Effect of 3HP vs Periodic 3HP vs 6H in HIV-Positive Individuals

Condizioni: Tuberculosis; HIV
NCT00814671

Completato

Study of Daily Rifapentine for Pulmonary Tuberculosis

Condizioni: Tuberculosis
NCT00460759

Terminato

Pharmacokinetic Issues of Moxifloxacin Plus Rifapentine

Condizioni: Mycobacterium Tuberculosis
NCT03730181

Reclutamento

Tuberculosis Clinical Trials Consortium Study 35

Condizioni: Latent Tuberculosis
NCT00023426

Completato

TBTC Study 25: Study of the Tolerability of Higher Doses of Rifapentine in the Treatment of Tuberculosis

Condizioni: Tuberculosis
NCT01574638

Completato

Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults

Condizioni: Tuberculosis
NCT02216331

Completato

PK Interaction Between Rifapentine or Rifampicin and a Single Dose of TMC207 in Healthy Subjects (TMC207-CL002)

Condizioni: Tuberculosis
NCT04600167

Non ancora reclutando

Preventive Treatment Of Latent Tuberculosis Infection In People With Diabetes Mellitus

Condizioni: Diabetes Mellitus; Tuberculosis
NCT01690403

Completato

Interaction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV Patients

Condizioni: Tuberculosis
NCT02430259

Completato

Efficacy of Weekly Rifapentine and Isoniazid for Tuberculosis Prevention

Condizioni: Silicosis; Tuberculosis
NCT00694629

Completato

TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment

Condizioni: Pulmonary Tuberculosis
NCT02208427

Stato sconosciuto

Toward a Safe and Reachable Preventive Therapy for LTBI: a Multicenter Randomized Controlled Study in Taiwan

Condizioni: Latent Tuberculosis Infection
NCT03886701

Completato

Doravirine, Rifapentine and Isoniazid Interaction

Condizioni: Latent Tuberculosis; Human Immunodeficiency Virus; Rifamycins Causing Adverse Effects in Therapeutic Use; Drug Interaction Potentiation
NCT02563327

Stato sconosciuto

Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis

Condizioni: Tuberculosis
NCT03266991

Reclutamento

Treatment of Latent Tuberculosis in Socially Marginalised Citizens

Condizioni: Compliance, Patient
NCT00164450

Completato

TBTC Study 26 PK: Rifapentine Pharmacokinetics in Children During Treatment of Latent TB Infection

Condizioni: Tuberculosis